SERUM MALONDIALDEHYDE-MODIFIED LOW-DENSITY LIPOPROTEIN LEVEL IS A RISK FOR AORTIC STIFFNESS IN MAINTENANCE HEMODIALYSIS PATIENTS

被引：0
|
作者：
Hou, Jia-Sian [1 ]
Lu, Chia-Wen [1 ]
Hsu, Bang-Gee [1 ,2 ]
机构：
[1] Hualien Tzu Chi Hosp, Div Nephrol, Buddhist Tzu Chi Med Fdn, Hualien, Taiwan
[2] Tzu Chi Univ, Sch Med, Hualien, Taiwan
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2020年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
P1266
引用
收藏
页码：1589 / 1589
页数：1
相关论文
共 50 条
  • [1] Serum Malondialdehyde-Modified Low-Density Lipoprotein Is a Risk Factor for Central Arterial Stiffness in Maintenance Hemodialysis Patients
    Hou, Jia-Sian
    Wang, Chih-Hsien
    Lai, Yu-Hsien
    Kuo, Chiu-Huang
    Lin, Yu-Li
    Hsu, Bang-Gee
    Tsai, Jen-Pi
    NUTRIENTS, 2020, 12 (07) : 1 - 10
  • [2] Serum Malondialdehyde-Modified Low-Density Lipoprotein as a Risk Marker for Peripheral Arterial Stiffness in Maintenance Hemodialysis Patients
    Liu, Wei-Nung
    Hsu, Yi-Chiung
    Lu, Chia-Wen
    Lin, Ssu-Chin
    Wu, Tsung-Jui
    Lin, Gen-Min
    MEDICINA-LITHUANIA, 2024, 60 (05):
  • [3] Serum Malondialdehyde-Modified Low-Density Lipoprotein Level May Be a Biomarker Associated with Aortic Stiffness Among Patients Undergoing Peritoneal Dialysis
    Chang, Yu-Chi
    Wang, Chih-Hsien
    Tang, Chi-Chong
    Lin, Yu-Li
    Lai, Yu-Hsien
    Kuo, Chiu-Huang
    Hsu, Bang-Gee
    LIFE-BASEL, 2024, 14 (11):
  • [4] Ezetimibe, an inhibitor of intestinal cholesterol absorption, decreases serum level of malondialdehyde-modified low-density lipoprotein in patients with hypercholesterolemia
    Ueda, Shin-ichiro
    Miyake, Ikuyo
    Takata, Kazuna
    Shimizu, Naomi
    Shirotani, Katsuro
    Ishida, Shiro
    Yonemitsu, Kazuaki
    Maeyama, Toyoaki
    Saito, Fumihiko
    Saito, Hiroyuki
    Yamagishi, Sho-ichi
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2011, 146 (03) : 420 - 421
  • [5] Malondialdehyde-Modified Low-Density Lipoprotein Is a Useful Marker to Identify Patients With Vulnerable Plaque
    Tajika, Kenichiro
    Okamatsu, Kentaro
    Takano, Masamichi
    Inami, Shigenobu
    Yamamoto, Masanori
    Murakami, Daisuke
    Kobayashi, Nobuaki
    Ohba, Takayoshi
    Hata, Noritake
    Seino, Yoshihiko
    Mizuno, Kyoichi
    CIRCULATION JOURNAL, 2012, 76 (09) : 2211 - 2217
  • [6] Associations of circulating malondialdehyde-modified low-density lipoprotein with lipoprotein subclasses in healthy men
    Takahashi, R.
    Okumura, K.
    Yoshikane, M.
    Ikeda, N.
    Murohara, T.
    EUROPEAN HEART JOURNAL, 2007, 28 : 211 - 211
  • [7] The ratio of malondialdehyde-modified low-density lipoprotein to low-density lipoprotein cholesterol is a key element for the recurrence of angina pectoris
    Higuchi, H.
    Endo, Y.
    Yamauchi, R.
    Sato, Y.
    Watabe, H.
    Yukawa, A.
    Suzuki, A.
    Eki, Y.
    Seo, Y.
    Aonuma, K.
    EUROPEAN HEART JOURNAL, 2011, 32 : 574 - 574
  • [8] MALONDIALDEHYDE-MODIFIED LOW-DENSITY LIPOPROTEINS IN PATIENTS WITH ATHEROSCLEROTIC DISEASE
    HOLVOET, P
    PEREZ, G
    ZHAO, Z
    BROUWERS, E
    BERNAR, H
    COLLEN, D
    JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (06): : 2611 - 2619
  • [9] Increased circulating levels of malondialdehyde-modified low-density lipoprotein in patients with coronary microvascular dysfunction
    Ito, Tsuyoshi
    Yokoi, Masashi
    Kitada, Shuichi
    Kawada, Yu
    Mizoguchi, Tatsuya
    Kikuchi, Shohei
    Goto, Toshihiko
    Seo, Yoshihiro
    JOURNAL OF CLINICAL LIPIDOLOGY, 2024, 18 (05) : e756 - e763
  • [10] Autoantibodies to malondialdehyde-modified low-density lipoprotein in patients with angiographically confirmed coronary artery disease
    McDowell, A
    Young, IS
    Wisdom, GB
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2002, 54 (12) : 1651 - 1657
12345